STUDY: MCP for Prostate

JOURNAL: Prostate Cancer and Prostatic Diseases, December 2003

AUTHORS: Dr. Stephen Strum

ABSTRACT: Men with prostate cancer who have not responded to conventional treatments may benefit from supplements containing a modified form of a fruit ingredient.

---

COMMENTARY: After 13 men with prostate cancer that did not respond to conventional treatment tried supplements containing modified fruit pectin (MCP) for 12 months, 7 of the 10 men who completed the study showed signs that their tumors were becoming less aggressive.

The study was sponsored by EcoNugenics, the company that sells the MCP supplements used in the current research.

All of the men underwent previous treatment for their tumors, including surgery and radiation, after which they had all experienced an increase in prostate specific antigen (PSA) in their blood, a sign their cancer was continuing to grow.

During the study, reported in the journal Prostate Cancer and Prostatic Diseases, Guess and his team asked 13 men with prostate cancer to take six capsules of MCP three times per day for one year, for a total daily dose of 14.4 grams.

Among the 10 patients who completed the study, seven experienced a slower rise in blood levels of PSA, a sign that their tumors were becoming less aggressive.